Menu Back toA Case Study : History of Expedited Development of Regkirona inj (Regdanvimab)
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations
A Case Study : History of Expedited Development of Regkirona inj (Regdanvimab)
Min Soo Kim
- Director, Head of Cell Science Department, Research & Development
- Celltrion, Korea, Republic of